Educational only — not medical advice. We explain the research so you can decide with clear eyes.

About this site
Peptide Atlas

Common pairing

Lean & Cut

fat-lossblood-sugar

Why people put these together

This pair is built for serious, appetite-driven weight loss and steadier blood sugar. Semaglutide is a well-proven GLP-1 medicine that curbs hunger and cravings, and cagrilintide copies a second "I'm full" hormone called amylin that works through a different appetite pathway. Together they are known as CagriSema, and large trials showed the combination drove more weight loss than either drug alone: about 20% of body weight in people without diabetes and around 14% in people with type 2 diabetes. Each drug has strong human evidence on its own, and the combination itself has now been tested in big phase 3 trials, which is unusual for a stack.

Keep in mind

These are prescription-grade injectable medicines, not supplements, and combining them causes more nausea and stomach upset than either one alone. Cagrilintide is still investigational in most places, product quality on the gray market is a real risk, and this stack needs a doctor's supervision and monitoring.

Compounds in this pairing